Evotec
在场
高管
查看带有其 42 名主要高管的组织结构图
Evotec 搜索最多的简介
- Werner Lanthaler, Chief Executive Officer (until Mar 2026)
- Elaine Sullivan, Member of the Supervisory Board
- Camilla Languille, Director
高管在Evotec变化
- Aurélie DalbiezAurélie Dalbiez 将于20246月15作为 Chief People Officer 加入公司 (新闻发布的2024四月17号).
- Mario Polywka 曾任 Director, 将于 20263月 升职为 Interim Chief Executive Officer and Director (新闻发布的2024一月4号).
- Werner Lanthaler, Chief Executive Officer, 将于 20263月 退休 (新闻发布的2024一月4号).
创建提醒
跟踪 Evotec 的高管变动
药店
Evotec 拥有 1,867 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
- Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).
药店 行业的其他推荐联系人
消息
Evotec 的最新新闻稿
- Breakpoint Therapeutics Announces Development Candidate Nomination and Start of IND-Enabling Activities of Potential Best-in-Class Polymerase Theta (Pol θ / POLQ) Inhibitor - Evotec
- Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline - Evotec
- Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic - Evotec
- Developing novel strategies against tuberculosis and malaria - Evotec
- Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV - Evotec
- Evotec SE: Invitation to Conference Call - Evotec
- Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb - Evotec
- Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies - Evotec
- Ad hoc: Evotec announces CEO transition - Evotec
- Evotec announces CEO transition - Evotec
- View more press releases Close
关于 Evotec 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Iris Löw-Friedrich 
